{"id":1677,"date":"2023-07-12T09:17:32","date_gmt":"2023-07-12T13:17:32","guid":{"rendered":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677"},"modified":"2023-07-12T09:17:32","modified_gmt":"2023-07-12T13:17:32","slug":"biocubafarma-y-empresa-mixta-china-firman-acuerdo-para-introducir-terapia-innovadora-contra-el-cancer-en-china","status":"publish","type":"post","link":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677","title":{"rendered":"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China"},"content":{"rendered":"<p>BioCubaFarma, anunci\u00f3 a trav\u00e9s de twitter un nuevo acuerdo de cooperaci\u00f3n con la empresa mixta china Changheber para la introducci\u00f3n de una inmunoterapia innovadora para el tratamiento del c\u00e1ncer en China.<\/p>\n<p>La Dra. Marta Ayala, directora general del Centro de Ingenier\u00eda Gen\u00e9tica y Biotecnolog\u00eda de Cuba (CIGB), visit\u00f3 la planta de Changheber en Changchun, China, donde se producen las vacunas QuimiHib en ensayos cl\u00ednicos de fase 3.<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p dir=\"ltr\" lang=\"es\">Contin\u00faa el fortalecimiento de la cooperaci\u00f3n entre China y Cuba en el campo de la Biotecnolog\u00eda. El nuevo acuerdo con la Empresa Mixta Changheber permitir\u00e1 la introducci\u00f3n en China de una inmunoterapia novedosa para el tratamiento del c\u00e1ncer. <a href=\"https:\/\/twitter.com\/hashtag\/CubaEsCiencia?src=hash&amp;ref_src=twsrc%5Etfw\">#CubaEsCiencia<\/a> \ud83c\udde8\ud83c\uddfa\ud83c\udde8\ud83c\uddf3 <a href=\"https:\/\/t.co\/xZa8I9Kc07\">pic.twitter.com\/xZa8I9Kc07<\/a><\/p>\n<p>\u2014 Eduardo Mart\u00ednez D\u00edaz (@EdMartDiaz) <a href=\"https:\/\/twitter.com\/EdMartDiaz\/status\/1673535605400059918?ref_src=twsrc%5Etfw\">June 27, 2023<\/a><\/p><\/blockquote>\n<p>&nbsp;<\/p>\n<p>Durante la visita, se firm\u00f3 un contrato de transferencia de tecnolog\u00eda del proyecto CIGB247, que permitir\u00e1 la investigaci\u00f3n, producci\u00f3n y desarrollo de un producto para el tratamiento de diferentes tipos de c\u00e1ncer. Se espera que la obtenci\u00f3n del registro sanitario de este producto en China permita su comercializaci\u00f3n en otros pa\u00edses y beneficie a la poblaci\u00f3n de ambos pa\u00edses.<\/p>\n<p>Esta colaboraci\u00f3n fortalece a\u00fan m\u00e1s las relaciones entre China y Cuba en el campo de la biotecnolog\u00eda y representa una oportunidad importante para el tratamiento del c\u00e1ncer en todo el mundo.<img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-1678\" src=\"http:\/\/instituciones.gtm.sld.cu\/cpscs\/wp-content\/uploads\/sites\/35\/2023\/07\/acuerdo-biocubafarma-china-2-e1687865418124-300x169.jpeg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/wp-content\/uploads\/sites\/35\/2023\/07\/acuerdo-biocubafarma-china-2-e1687865418124-300x169.jpeg 300w, https:\/\/instituciones.gtm.sld.cu\/cpscs\/wp-content\/uploads\/sites\/35\/2023\/07\/acuerdo-biocubafarma-china-2-e1687865418124.jpeg 580w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BioCubaFarma, anunci\u00f3 a trav\u00e9s de twitter un nuevo acuerdo de cooperaci\u00f3n con la empresa mixta china Changheber para la introducci\u00f3n de una inmunoterapia innovadora para el tratamiento del c\u00e1ncer en China. La Dra. Marta Ayala, directora general del Centro de Ingenier\u00eda Gen\u00e9tica y Biotecnolog\u00eda de Cuba (CIGB), visit\u00f3 la planta de Changheber en Changchun, China, &hellip; <\/p>\n<p><a class=\"more-link btn\" href=\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677\">Seguir leyendo<\/a><\/p>\n","protected":false},"author":101,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0},"categories":[7],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China -\" \/>\n<meta property=\"og:description\" content=\"BioCubaFarma, anunci\u00f3 a trav\u00e9s de twitter un nuevo acuerdo de cooperaci\u00f3n con la empresa mixta china Changheber para la introducci\u00f3n de una inmunoterapia innovadora para el tratamiento del c\u00e1ncer en China. La Dra. Marta Ayala, directora general del Centro de Ingenier\u00eda Gen\u00e9tica y Biotecnolog\u00eda de Cuba (CIGB), visit\u00f3 la planta de Changheber en Changchun, China, &hellip; Seguir leyendo\" \/>\n<meta property=\"og:url\" content=\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-12T13:17:32+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/instituciones.gtm.sld.cu\/cpscs\/wp-content\/uploads\/sites\/35\/2023\/07\/acuerdo-biocubafarma-china-2-e1687865418124-300x169.jpeg\" \/>\n<meta name=\"author\" content=\"orisbel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"orisbel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677\",\"url\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677\",\"name\":\"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China -\",\"isPartOf\":{\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#website\"},\"datePublished\":\"2023-07-12T13:17:32+00:00\",\"dateModified\":\"2023-07-12T13:17:32+00:00\",\"author\":{\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#\/schema\/person\/aec961a251793f8085cc0b9446efd2f0\"},\"breadcrumb\":{\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#website\",\"url\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#\/schema\/person\/aec961a251793f8085cc0b9446efd2f0\",\"name\":\"orisbel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13679ae77d35a21504ba12a772bcd613?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13679ae77d35a21504ba12a772bcd613?s=96&d=mm&r=g\",\"caption\":\"orisbel\"},\"sameAs\":[\"https:\/\/instituciones.gtm.sld.cu\/\/cpscs\/\"],\"url\":\"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?author=101\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677","og_locale":"es_ES","og_type":"article","og_title":"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China -","og_description":"BioCubaFarma, anunci\u00f3 a trav\u00e9s de twitter un nuevo acuerdo de cooperaci\u00f3n con la empresa mixta china Changheber para la introducci\u00f3n de una inmunoterapia innovadora para el tratamiento del c\u00e1ncer en China. La Dra. Marta Ayala, directora general del Centro de Ingenier\u00eda Gen\u00e9tica y Biotecnolog\u00eda de Cuba (CIGB), visit\u00f3 la planta de Changheber en Changchun, China, &hellip; Seguir leyendo","og_url":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677","article_published_time":"2023-07-12T13:17:32+00:00","og_image":[{"url":"http:\/\/instituciones.gtm.sld.cu\/cpscs\/wp-content\/uploads\/sites\/35\/2023\/07\/acuerdo-biocubafarma-china-2-e1687865418124-300x169.jpeg"}],"author":"orisbel","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"orisbel","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677","url":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677","name":"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China -","isPartOf":{"@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#website"},"datePublished":"2023-07-12T13:17:32+00:00","dateModified":"2023-07-12T13:17:32+00:00","author":{"@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#\/schema\/person\/aec961a251793f8085cc0b9446efd2f0"},"breadcrumb":{"@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?p=1677#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/instituciones.gtm.sld.cu\/cpscs"},{"@type":"ListItem","position":2,"name":"BioCubaFarma y empresa mixta china firman acuerdo para introducir terapia innovadora contra el c\u00e1ncer en China"}]},{"@type":"WebSite","@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#website","url":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#\/schema\/person\/aec961a251793f8085cc0b9446efd2f0","name":"orisbel","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13679ae77d35a21504ba12a772bcd613?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13679ae77d35a21504ba12a772bcd613?s=96&d=mm&r=g","caption":"orisbel"},"sameAs":["https:\/\/instituciones.gtm.sld.cu\/\/cpscs\/"],"url":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/?author=101"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=\/wp\/v2\/posts\/1677"}],"collection":[{"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=\/wp\/v2\/users\/101"}],"replies":[{"embeddable":true,"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1677"}],"version-history":[{"count":1,"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=\/wp\/v2\/posts\/1677\/revisions"}],"predecessor-version":[{"id":1679,"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=\/wp\/v2\/posts\/1677\/revisions\/1679"}],"wp:attachment":[{"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/instituciones.gtm.sld.cu\/cpscs\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}